U.S. markets close in 5 hours 58 minutes
  • S&P 500

    3,636.08
    -4.39 (-0.12%)
     
  • Dow 30

    29,152.40
    -73.21 (-0.25%)
     
  • Nasdaq

    10,742.35
    +4.84 (+0.05%)
     
  • Russell 2000

    1,676.12
    +1.18 (+0.07%)
     
  • Crude Oil

    79.89
    -1.34 (-1.65%)
     
  • Gold

    1,677.30
    +8.70 (+0.52%)
     
  • Silver

    19.06
    +0.35 (+1.86%)
     
  • EUR/USD

    0.9776
    -0.0043 (-0.44%)
     
  • 10-Yr Bond

    3.6860
    -0.0610 (-1.63%)
     
  • GBP/USD

    1.1129
    +0.0006 (+0.05%)
     
  • USD/JPY

    144.4890
    +0.0460 (+0.03%)
     
  • BTC-USD

    19,438.63
    +398.07 (+2.09%)
     
  • CMC Crypto 200

    444.47
    +1.04 (+0.23%)
     
  • FTSE 100

    6,858.46
    -23.13 (-0.34%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

Sotera Health to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference

·1 min read

CLEVELAND, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 7:30 am Eastern. In his presentation, Mr. Petras will provide an update on Sotera Health’s businesses. Sotera Health management, including Chief Financial Officer Scott Leffler, will participate in one-on-one meetings with investors during the conference.

Investors and the general public are invited to listen to the live webcast of Mr. Petras’ presentation by accessing the link on the Sotera Health website under the Investor Relations section: https://investors.soterahealth.com/events-and-presentations. A replay and slides for download will also be made available.

About Sotera Health:

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

INVESTOR RELATIONS CONTACTS:

Sally J. Curley, IRC

Jenny Kobin

Curley Global IR, LLC

IR Advisory Solutions

IR@soterahealth.com

IR@soterahealth.com

MEDIA CONTACT:

Kristin Gibbs

Chief Marketing Officer, Sotera Health

kgibbs@soterahealth.com

Source: Sotera Health Company